Assentia Unveils New SaaS-Based Applications
Assentia has unveiled two new proprietary, SaaS-based applications, GrantPay™ and GrantPact™, designed to aid Assentia in merging its global knowledge in clinical trial contract negotiations and investigative site payments with functional technology platforms.
Assentia utilizes GrantPay™ to provide investigator site payments on a multi-currency, global scale in addition to granular forecasting and customizable reporting to assist its clients' needs and obligations.
GrantPact™ is Assentia's proprietary platform supporting its international team in negotiating and tracking global clinical trial agreements, including housing previously negotiated legal clauses with study sites worldwide.
Reference
Assentia Unveils Proprietary Software, GrantPay™ and GrantPact™, to Aid in Accelerating Clinical Trial Study-Startup and Investigator Payments. (2023, March 9). Cision PR Newswire.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
